Taichiro Imahori

Dr. Taichiro Imahori

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KTKazuhiro Tanaka
Kazuhiro Tanaka
TSTakashi Sasayama
Takashi Sasayama
YIYasuhiro Irino
Yasuhiro Irino
KTKumi Takata
Kumi Takata
HNHiroaki Nagashima
Hiroaki Nagashima
EKEiji Kohmura
Eiji Kohmura
The mechanistic target of rapamycin (mTOR) is hyperactivated in many types of cancer, rendering it a compelling drug target; however, the impact of mTOR inhibition on metabolic reprogramming in cancer is incompletely understood. Here, by integrating metabolic and functional studies in glioblastoma multiforme (GBM) cell lines, preclinical models, and clinical samples, we demonstrate that the compensatory upregulation of glutamine metabolism promotes resistance to mTOR kinase inhibitors. Metabolomic studies in GBM cells revealed that glutaminase (GLS) and glutamate levels are elevated following mTOR kinase inhibitor treatment. Moreover, these mTOR inhibitor–dependent metabolic alterations were confirmed in a GBM xenograft model. Expression of GLS following mTOR inhibitor treatment promoted GBM survival in an α-ketoglutarate–dependent (αKG-dependent) manner. Combined genetic and/or pharmacological inhibition of mTOR kinase and GLS resulted in massive synergistic tumor cell death and growth inhibition in tumor-bearing mice. These results highlight a critical role for compensatory glutamine metabolism in promoting mTOR inhibitor resistance and suggest that rational combination therapy has the potential to suppress resistance.

1 December 2017 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
TITaichiro Imahori
Taichiro Imahori
KTKazuhiro Tanaka
Kazuhiro Tanaka
AAAtsushi Arai
Atsushi Arai
RSRyoji Shiomi
Ryoji Shiomi
DFDaigo Fujiwara
Daigo Fujiwara
EKEiji Kohmura
Eiji Kohmura

1 September 2020 in World Neurosurgery
Verified
Journal Article
Closed access
TITaichiro Imahori
Taichiro Imahori
SMShinichi Miura
Shinichi Miura
MSMasahiro Sugihara
Masahiro Sugihara
TMTakashi Mizobe
Takashi Mizobe
HAHideo Aihara
Hideo Aihara
EKEiji Kohmura
Eiji Kohmura

1 May 2018 in Brain Research
Verified
Journal Article
Closed access
YYYusuke Yamamoto
Yusuke Yamamoto
KHKohkichi Hosoda
Kohkichi Hosoda
TITaichiro Imahori
Taichiro Imahori
JTJun Tanaka
Jun Tanaka
KMKazuya Matsuo
Kazuya Matsuo
EKEiji Kohmura
Eiji Kohmura

1 April 2021 in Radiology Case Reports
Verified
Journal Article
Open access
MNMasahiro Nakahara
Masahiro Nakahara
TITaichiro Imahori
Taichiro Imahori
KTKazuhiro Tanaka
Kazuhiro Tanaka
YOYusuke Okamura
Yusuke Okamura
AAAtsushi Arai
Atsushi Arai
EKEiji Kohmura
Eiji Kohmura
Intracranial vessel dissection is a procedural complication associated with endovascular treatment. However, there have been few reports on its potential causes and management during mechanical thrombectomy. In approximately 250 cases of mechanical thrombectomy over the past 5 years at our institution, iatrogenic intracranial dissection occurred in 2 patients (0.8%). In this report, we described these 2 cases that were rescued through emergent stenting. Mechanical thrombectomy, using both a stent retriever and an aspiration catheter, was performed for acute middle cerebral artery M2 occlusion in Patient 1 (a 69-year-old man) and for distal M1 occlusion in Patient 2 (an 83-year-old woman). In both cases, recanalization was achieved with the procedure, but irregular stenosis developed at the initially nonoccluded, but mildly arteriosclerotic, M1, after recanalization. During the thrombectomy procedure, the aspiration catheter sifted up to the arteriosclerotic M1. In both cases, the lesions were considered vessel dissection, due to a shift of the aspiration catheter tip into the arteriosclerotic vessel wall. Repeated percutaneous angiography with antithrombotic therapy failed to improve the lesions and to maintain the antegrade blood flow. Finally, lesions in each patient were successfully rescued through the use of emergent stenting. A drug-eluting stent for coronary use was deployed in Patient 1, and an Enterprise stent was applied in Patient 2. Inadvertent shift of the aspiration catheter into arteriosclerotic vessels can cause a serious intracranial vessel dissection. When performing mechanical thrombectomy, intracranial stents need to be available as rescue treatment devices to manage refractory iatrogenic intracranial vessel dissection.

1 May 2017 in Neuroscience
Verified
Journal Article
Closed access
TITaichiro Imahori
Taichiro Imahori
KHKohkichi Hosoda
Kohkichi Hosoda
TNTomoaki Nakai
Tomoaki Nakai
YYYusuke Yamamoto
Yusuke Yamamoto
YIYasuhiro Irino
Yasuhiro Irino
EKEiji Kohmura
Eiji Kohmura